Exact Mass: 510.2379

Exact Mass Matches: 510.2379

Found 500 metabolites which its exact mass value is equals to given mass value 510.2379, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Deuteroporphyrin IX

3-[20-(2-carboxyethyl)-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-4-yl]propanoic acid

C30H30N4O4 (510.2267)

Deuteroporphyrin IX is a non-natural dicarboxylic porphyrin. Deuteroporphyrins are porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. Deuteroporphyrin IX is described as a fecal porphyrin in patients with endemic chronic arsenic poisoning. (Environmental Sciences (Tokyo, Japan) (2001), 8(6), 561-570.). Excess accumulation of the biosynthetic intermediate protoporphyrin can lead to extensive tissue damage upon exposure to light since protoporpyhyrin is a potent photosensitizing agent, giving rise to membrane-destroying oxygen radicals or singlet oxygen. For instance, in the human porphyria disease porphyria variegata, a genetic deficiency in a heme biosynthetic enzyme, protoporphyrinogen oxidase, leads to protoporphyrin accumulation and lightdependent skin photosensitivity. Horseradish peroxidase (HRP) in the presence of glutathione (GSH) could oxidize the non-natural porphyrin deuteroporphyrin IX, which is closely related to protoporphyrin IX. The product is a unique green chlorin. One of the pyrrole rings had been modified by addition of an hydroxy and an oxo group, thus giving the characteristic reduced pyrrole ring of the chlorine. Of most importance for human medicine, peroxidative enzymes present in mammalian cells can also carry out these GSH-dependent oxidative conversions of protoporphyrin and deuteroporphyrin. (PMID: 10334939). Deuteroporphyrin IX is a non-natural dicarboxylic porphyrin. Deuteroporphyrins are porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. Deuteroporphyrin IX is described as a fecal porphyrin in patients with endemic chronic arsenic poisoning. (Environmental Sciences (Tokyo, Japan) (2001), 8(6), 561-570.)

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulfonyl]piperazin-1-yl)ethyl)quinazoline

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulphonyl]piperazin-1-yl)ethyl)quinazoline

C27H34N4O4S (510.2301)

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R),2R,3S*))-

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-

C24H38N4O6S (510.2512)

Deuteroporphyrin

granatumin K|methyl rel-(1R,6S,6aS,8R,9S,9aR,9bS,11aR,12R)-12-(acetyloxy)-1-(furan-3-yl)-1,3,6,6a,7,8,9,9a,9b,10,11,11a-dodecahydro-6a-hydroxy-8,9a,11a-trimethyl-3-oxo-6,8-methanocyclopenta[5,6]naphtho[2,1-c]pyran-9-acetate

granatumin K|methyl rel-(1R,6S,6aS,8R,9S,9aR,9bS,11aR,12R)-12-(acetyloxy)-1-(furan-3-yl)-1,3,6,6a,7,8,9,9a,9b,10,11,11a-dodecahydro-6a-hydroxy-8,9a,11a-trimethyl-3-oxo-6,8-methanocyclopenta[5,6]naphtho[2,1-c]pyran-9-acetate

C29H34O8 (510.2254)

Manumycin B

C28H34N2O7 (510.2366)

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

C26H38O10 (510.2465)

Ile Thr Tyr Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C23H34N4O9 (510.2326)

3-(2-methylbutanoyl)-4-(3-methylbutanoyl)sucrose

C22H38O13 (510.2312)

3,4-di(3-methylbutanoyl)sucrose

C22H38O13 (510.2312)

C30H30N4O4 (510.2267)

Janus Green B

C30H31ClN6 (510.2299)

4,4-Bis(2,2-diphenylvinyl)biphenyl

C40H30 (510.2347)

TG-46

C26H34N6O3S (510.2413)

ent-6,11-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester

C26H38O10 (510.2465)

ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyrasyl ester

C26H38O10 (510.2465)

Pinaverium

4-[(2-BROMO-4,5-DIMETHOXY-PHENYL)METHYL]-4-[2-[2-(6,6-DIMETHYLNORPINAN-2-YL)ETHOXY]ETHYL]-1-OXA-4-AZONIACYCLOHEXANE BROMIDE

C26H41BrNO4+ (510.2219)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

Epiamastatin · HCl

C21H39ClN4O8 (510.2456)

1,3-bis[(acryloxymethyl)phenethyl]tetramethyldisiloxane

C28H38O5Si2 (510.2258)

Amastatin · HCl

C21H39ClN4O8 (510.2456)

N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[3-(4-morpholinylmethy - l)phenyl]amino]-4-pyrimidinyl]amino]benz

C26H34N6O3S (510.2413)

2-(4-Hydroxyphenyl)-3-methyl-1-[4-[2-(1-piperidinyl)ethoxy]benzyl]-1H-indol-5-ol hydrochloride hydrate

C29H35ClN2O4 (510.2285)

Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH

C28H34N2O7 (510.2366)

Flordipine

C26H33F3N2O5 (510.2341)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker

Deuteroporphyrin

C30H30N4O4 (510.2267)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D003879 - Dermatologic Agents

2-[2-butyl-4-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5-imidazo[4,5-c]pyridinyl]-N,N-dimethylacetamide

C28H30N8O2 (510.2492)

Tetrahydroasterriquinone

C32H34N2O4 (510.2518)

C26H38O10 (510.2465)

{"Ingredient_id": "HBIN000099","Ingredient_name": "10-debenzoyal-2alpha-acetoxy-brevifoliol","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1O)C(C)(C)O)OC(=O)C)O)OC(=O)C)C)OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26022","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

10-debenzoyl-2α-acetoxy-brevifoliol

C26H38O10 (510.2465)

{"Ingredient_id": "HBIN000100","Ingredient_name": "10-debenzoyl-2\u03b1-acetoxy-brevifoliol","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C(=C)C3C(C2(CC1O)C(C)(C)O)OC(=O)C)O)OC(=O)C)C)OC(=O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4800","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5α,7β,10β,13α-tetrahydroxy-2α,9α,15-tri-acetoxy-11(15→1)-abeo-taxa-4(20),11-diene

C26H38O10 (510.2465)

{"Ingredient_id": "HBIN011388","Ingredient_name": "5\u03b1,7\u03b2,10\u03b2,13\u03b1-tetrahydroxy-2\u03b1,9\u03b1,15-tri-acetoxy-11(15\u21921)-abeo-taxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21145","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

adenostemmmoside b

C26H38O10 (510.2465)

{"Ingredient_id": "HBIN014697","Ingredient_name": "adenostemmmoside b","Alias": "NA","Ingredient_formula": "C26H38O10","Ingredient_Smile": "CC1(CCCC2(C1CCC34C2(C(CC(C3)C(=C)C4=O)O)O)C)C(=O)OC5C(C(C(C(O5)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23673","TCMSP_id": "NA","TCM_ID_id": "7160","PubChem_id": "NA","DrugBank_id": "NA"}

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 3,10-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H38O10 (510.2465)

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,4s,5r,9r,10r,11s,13s)-10,11-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H38O10 (510.2465)

(1r,2r,13s,15s)-6,8-dihydroxy-5-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4(9),5,7,11-tetraene-10,14-dione

(1r,2r,13s,15s)-6,8-dihydroxy-5-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4(9),5,7,11-tetraene-10,14-dione

C29H34O8 (510.2254)

(2e,4s)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyloct-2-enimidic acid

(2e,4s)-n-[(1s,5s,6r)-5-hydroxy-5-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-2,4-dimethyloct-2-enimidic acid

methyl 2-[2-(acetyloxy)-4-formyl-13-(furan-3-yl)-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-5,11-dien-9-yl]acetate

C29H34O8 (510.2254)

5-(acetyloxy)-12-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C29H34O8 (510.2254)

(1r,4ar,5s,6s,8s,8ar)-8a-[(acetyloxy)methyl]-6-hydroxy-5,6-dimethyl-5-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-hexahydrospiro[naphthalene-1,2'-oxiran]-8-yl benzoate

C29H34O8 (510.2254)

(1r,4s,9r,12s,13s,16r,17r,18r)-18-hydroxy-17-(hydroxymethyl)-12-methyl-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-5-en-7-one

(1r,4s,9r,12s,13s,16r,17r,18r)-18-hydroxy-17-(hydroxymethyl)-12-methyl-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-5-en-7-one

12'-acetyl-10'-hydroxy-7,9'-dimethyl-4'-methylidene-6-[(1e)-3-oxobut-1-en-1-yl]-4,7,8,8a-tetrahydro-3ah-6',14'-dioxaspiro[cyclohepta[b]furan-3,13'-tricyclo[8.4.0.0³,⁷]tetradecan]-11'-ene-2,5'-dione

(1'r,3r,3'r,3ar,7r,7'r,8as,9's,10'r)-12'-acetyl-10'-hydroxy-7,9'-dimethyl-4'-methylidene-6-[(1e)-3-oxobut-1-en-1-yl]-4,7,8,8a-tetrahydro-3ah-6',14'-dioxaspiro[cyclohepta[b]furan-3,13'-tricyclo[8.4.0.0³,⁷]tetradecan]-11'-ene-2,5'-dione

C29H34O8 (510.2254)

(1'r,2r,2's,4'r,5's,6'r,8'r,9's,11'r)-5'-[(2s,3as,5r,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate

(1'r,2r,2's,4'r,5's,6'r,8'r,9's,11'r)-5'-[(2s,3as,5r,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate

C26H38O10 (510.2465)

18-hydroxy-17-(hydroxymethyl)-12-methyl-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-5-en-7-one

C26H38O10 (510.2465)

11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraene-13,17-dione

C29H34O8 (510.2254)

(7s,10s,13s)-10,13-dibenzyl-8,11,14-trihydroxy-3,9,12,15-tetraazatricyclo[14.4.0.0³,⁷]icosa-1(20),8,11,14,16,18-hexaen-2-one

C30H30N4O4 (510.2267)

(1r,2r,7s,16s,18s)-11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraene-13,17-dione

(1r,2r,7s,16s,18s)-11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,9,11,14-tetraene-13,17-dione

C29H34O8 (510.2254)

2,8-bis(acetyloxy)-5-{5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl}-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

C26H38O10 (510.2465)

(1r,2s,3r,6r,9s,10s,11r,12s,15r,17s)-2,9-dihydroxy-6,11-dimethyl-16-methylidene-17-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[13.2.1.0¹,¹².0³,¹¹.0⁶,¹⁰]octadecan-7-one

(1r,2s,3r,6r,9s,10s,11r,12s,15r,17s)-2,9-dihydroxy-6,11-dimethyl-16-methylidene-17-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-oxapentacyclo[13.2.1.0¹,¹².0³,¹¹.0⁶,¹⁰]octadecan-7-one

C26H38O10 (510.2465)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,3r,4s,5r,9s,10s,11s,13s)-3,11-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,3r,4s,5r,9s,10s,11s,13s)-3,11-dihydroxy-5,9-dimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H38O10 (510.2465)

(1s,2r,5s,6s,7s,9r,12r)-5-(acetyloxy)-12-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C29H34O8 (510.2254)

6,8-dihydroxy-5-(2-hydroxy-3-methylbut-3-en-1-yl)-13-methoxy-17,17-dimethyl-15-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4(9),5,7,11-tetraene-10,14-dione

(1'r,2r,2's,4'r,5's,6'r,8'r,9's)-5'-[(2s,3as,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate

(1'r,2r,2's,4'r,5's,6'r,8'r,9's)-5'-[(2s,3as,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-2'-(acetyloxy)-9'-hydroxy-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-11'-yl 2-methylpropanoate

C29H34O8 (510.2254)